Song Y, Huang Y, Zhou F, Ding J, Zhou W (2022) Macrophage-targeted nanomedicine for chronic diseases immunotherapy
Glutathione deficiency is rare outside specific clinical contexts: chronic liver disease, HIV/AIDS, sepsis, or genetic disorders affecting glutathione synthesis (glutathione synthetase deficiency)
342 Furthermore, exosomes can easily cross biological barriers, such as the blood-brain barrier (BBB), which has good application potential in extra-hepatic-targeted NADs delivery
if freezing solutions, aliquot into single-use portions
That means every treatment we offer is backed by clinical science and delivered by licensed medical professionals